Leukemic thyroiditis as the initial relapsing sign in a patient with acute lymphocytic leukemia and blast expression of the neural cell adhesion molecule

American Journal of Hematology

Volumn 55, Issue 4, 1997, Pages 212-215

  Byrd, John C ^a,b   Dow, Nancy S ^a   Gaertner, Erich ^a   Hargis, Jeffrey B ^a,b   Raber, Tracy R ^a   Burrell, Linda ^a,b   Weiss, Raymond B ^a,b  

^a WALTER REED ARMY MEDICAL CENTER   (United States)

^b UNIFORMED SERVICES UNIVERSITY OF THE HEALTH SCIENCES   (United States)

Author keywords

Acute lymphocytic leukemia; Extramedullary leukemia; Neural cell adhesion molecule; Thyroiditis

Indexed keywords

ACUTE LYMPHOCYTIC LEUKEMIA; ADULT; ARTICLE; CANCER RECURRENCE; CASE REPORT; CLINICAL FEATURE; FEMALE; HUMAN; PRIORITY JOURNAL; RELAPSE; T CELL LEUKEMIA; THYROIDITIS;

ADULT; ANTIGENS, CD56; FEMALE; HUMANS; LEUKEMIA, T-CELL, ACUTE; LYMPHOCYTE ACTIVATION; NEURAL CELL ADHESION MOLECULES; RECURRENCE; THYROIDITIS, SUBACUTE;

EID: 0030789631     PISSN: 03618609     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-8652(199707)55:4<212::AID-AJH9>3.0.CO;2-V     Document Type: Article

References (28)

1. Finklestein JZ, Miller DR, Feusner J, et al: Treatment of overt isolated testicular relapse in children on therapy for acute lymphoblastic lymphoma. Cancer 73:219-223, 1994.
2. Pinkel D, Woo S: Prevention and treatment of meningeal leukemia in children. Blood 84:355-366, 1994.
3. Bunin NJ, Pui CH, Hustu O, et al: Unusual extramedullary relapses in children with acute lymphoblastic leukemia. J Pediatr 99:665-668, 1986.
4. Hwang WL, Gau JP, Hu HT, et al: Isolated extramedullary relapse of acute lymphoblastic leukemia presenting as an intraspinal mass. Acta Haematol 91:46-48, 1994.
5. Dunn NL, McWilliams NB, Mohanakumar T: Clinical and immunological correlates of leukemia cutis in childhood. Cancer 50:2049-2051, 1982.
6. Janckila AJ, Yam LT, Li CY: Immunocytochemical diagnosis of acute leukemia with pleural involvement. Acta Cytol 29:67-72, 1985.
7. Terry LN, Kligerman MM: Pericardial and myocardial involvement by lymphomas and leukemias. Cancer 25:1003-1008, 1970.
8. Goel RG, Amin I: Acute lymphoblastic leukemia with swellings of thyroid and hard palate. Indian Pediatr 20:614-615, 1983.
9. Foresti V, Parisio E, Scolari N, et al: Primary hypothyroidism due to leukemic infiltration of the thyroid gland. J Endocrinol Invest 11:43-45, 1988.
10. Barcos M, Lane W, Gomez GA, et al: An autopsy study of 1206 acute and chronic leukemias (1958-1982). Cancer 60:827-837, 1987.
11. Smith WS, Burke MJ, Wong KY: Hypopyon in acute lymphoblastic leukemia. Med Pediatr Oncol 12:258-259, 1984.
12. Scott AA, Kopecky KJ, Grogan TM, et al: CD56: A determinant of extramedullary and central nervous system involvement in acute myeloid leukemia. Presented at: United States and Canadian Academy of Pathology Meeting. San Francisco, March 12-18, 1994.
13. Byrd JC, Weiss RB: Recurrent Granulocytic Sarcoma: An unusual variation of acute myelogenous leukemia associated with 8;21 chromosomal translocation and blast expression of the neural cell adhesion molecule. Cancer 73:2107-2112, 1994.
14. Seymour JF, Pierce SA, Kantarjian HM, et al: Investigation of karyotypic, morphologic, and clinical features in patients with acute myeloid leukemia blast cells expressing the neural cell adhesion molecule (CD56). Leukemia 8:823-826, 1994.
15. Iizuka Y, Aiso M, Oshimi K, et al: Myeloblastoma formation in acute myeloid leukemia. Leuk Res 16:665-671, 1992.
16. Nguyen C, Mattei MG, Mattei JF, et al: Localization of the human NCAM gene to band q23 of chromosome 11. J Cell Biol 102:711-715, 1986.
17. Cunningham BA, Hemperly JJ, Murray BA, et al: Neural cell adhesion molecule: Structure, immunoglobulin-like domains, cell surface modulation, and alternative RNA splicing. Science 236:799-806, 1987.
18. Rutishauser U, Acheson A, Hall AK, et al: The neural cell adhesion molecule (NCAM) as a regulator of cell-cell interactions. Science 240:53-57, 1988.
19. Garin-Chesa P, Fellinger EJ, Huvos AG, et al: Immunohistochemical analysis of neural cell adhesion molecules. Am J Pathol 139:275-286, 1991.
20. Van Camp B, Durie BGM, Spier C, et al: Plasma cells in multiple myeloma express a natural killer cell-associated antigen: CD56(NKH-1; Leu-19). Blood 76:377-382, 1990.
21. Kern WF, Spier CM, Hanneman EH, et al: Neural cell adhesion molecule-positive peripheral t-cell lymphoma: A rare variant with a propensity for unusual sites of involvement. Blood 79:2432-2437, 1992.
22. Kern WF, Spier CM, Miller TP, et al: NCAM (CD56)-positive malignant lymphoma. Leuk Lymph 12:1-10, 1993.
23. Wong KF, Chan JKC, NG CS: CD56 (NCAM)-positive malignant lymphoma. Leuk Lymph 14:29-36, 1994.
24. Macon WR, Williams ME, Greer JP, et al: Natural killer-like t-cell lymphomas: Aggressive lymphomas of t-large granular lymphocytes. Blood 87:1474-1483, 1996.
25. Emile JF, Boulland ML, Haioun C, et al: CD5-CD56+ T-cell receptor silent peripheral t-cell lymphomas are natural killer cell lymphomas. Blood 87:1466-1473, 1996.
26. Byrd JC, Edenfield WJ, Arthur DC, et al: Extramedullary leukemia is associated with pretreatment cytogenetic abnormalities in patients with acute myeloid leukemia. Results of CALGB 8461. Blood 86:43a (Abstr 161), 1995.
27. Kaplan J, Ravindranath Y, Inoue S: T-cell acute lymphoblastic leukemia with natural killer cell phenotype. Am J Hematol 22:355-364, 1986.
28. Meckenstock G, Fonatsch CH, Heyll A, et al: T-cell receptor expressing acute leukemia emerging from sideroblastic anemia: Morphological, immunological, and cytogenetic features. Leuk Res 4:379-384, 1992.